| 摘要 |
A pharmaceutical composition containing at least one antibiotic from the bleomycin family and at least one protein for inactivating said bleomycin(s) which may be administered before, during and/or after administration of the bleomycin(s), in order to reduce the side-effects caused by said bleomycins in some organs. The proteins for inactivating the bleomycins can be produced by a transformed Tolypocladium geodes strain. |
